A Phase I Safety, PK and PD Study of KW-2478 in Patients With Multiple Myeloma, Chronic Lymphocytic Leukaemia or B-cell Non-Hodgkin's Lymphoma
This study has been completed.
Kyowa Hakko Kirin UK, Ltd.
Information provided by:
Kyowa Kirin Pharmaceutical Development, Inc.
First received: April 5, 2007
Last updated: January 31, 2011
Last verified: January 2011
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||January 2011|
|Primary Completion Date:||August 2010 (Final data collection date for primary outcome measure)|